Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127513691 | 12751369 | 1 | I | 20160914 | 0 | 20160916 | 20160916 | DIR | US-FDA-350779 | FDA-CTU | 71.69 | YR | M | N | 90.00000 | KG | 20160916 | N | PH | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127513691 | 12751369 | 1 | PS | Atorvastatin | ATORVASTATIN | 1 | Oral | D | D | 0 | 10 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127513691 | 12751369 | 1 | Lipids increased |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127513691 | 12751369 | Diplopia | |
| 127513691 | 12751369 | Dry eye | |
| 127513691 | 12751369 | Eyelid ptosis | |
| 127513691 | 12751369 | Fatigue | |
| 127513691 | 12751369 | Pain | |
| 127513691 | 12751369 | Pain in extremity |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | CASEID | RPSR COD |
|---|---|---|
| 127513691 | 12751369 | HP |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127513691 | 12751369 | 1 | 20160822 | 20160915 | 0 |